Chemomab jumps on positive liver scarring trial results
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
Calyxo, Inc., a medical device company developing innovative solutions for patients with kidney stones, has announced positive new study results...
CVAC System (Photo: Business Wire)CVAC System ProcedureMulti-Center ASPIRE 1-Year Study Results Show Healthcare Consumption Events are Significantly Lower after SURE...